Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech gross margin
Gross margin is gross profit as a percentage of revenue.
Goldenwell Biotech's gross margin for the twelve months ending Jun 30, 2026 was 21.8%. For fiscal 2025 it was 21.8%, against 46.0% the year before. The highest annual figure on record is 52.7% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21.8% | −24.2 |
| FY2024 | Dec 31, 2024 | 46.0% | +9.8 |
| FY2023 | Dec 31, 2023 | 36.3% | −16.4 |
| FY2022 | Dec 31, 2022 | 52.7% | +0.2 |
| FY2021 | Dec 31, 2021 | 52.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 21.8% | −28.2 |
| Q2 FY2024 | Jun 30, 2024 | 50.4% | +0.4 |
| Q4 FY2023 | Dec 31, 2023 | 28.1% | −24.6 |
| Q3 FY2023 | Sep 30, 2023 | 48.7% | −3.9 |
| Q2 FY2023 | Jun 30, 2023 | 50.0% | −2.6 |
| Q1 FY2023 | Mar 31, 2023 | 50.0% | −2.5 |
| Q3 FY2022 | Sep 30, 2022 | 52.7% | +0.2 |
| Q2 FY2022 | Jun 30, 2022 | 52.5% | +0.0 |
| Q1 FY2022 | Mar 31, 2022 | 52.6% | – |
| Q4 FY2021 | Dec 31, 2021 | 52.5% | – |
| Q3 FY2021 | Sep 30, 2021 | 52.5% | – |
| Q2 FY2021 | Jun 30, 2021 | 52.5% | – |
See a number that looks wrong?